Albuminuria and cardiovascular disease risk ( CVD )
There is evidence from the HOPE study that the presence of albuminuria indicates increased risk for myocardial infarction, stroke, cardiovascular death, congestive heart failure, and all-cause mortality.
Summary results:
outcomes at median 4.5 years | with microalbuminuria | without microalbuminuriaa | adjusted RR (95% CI) |
major cardiovascular events | 23% | 14% | 1.83 (1.64-2.05) |
all-cause mortality | 18% | 9% | 2.09 (1.84-2.38) |
CHF hospital admission | 6% | 2% | 3.23 (2.54-4.10) |
Authors of the study point out that many cardiovascular risk factors are associated with microalbuminuria, including smoking, hypertension, dyslipidaemia, hyperhomocystinemia, dietary protein, and markers of acute phase response. There is a need for further research to clearly assess the independent cardiovascular risk that occurs as a result of the presence (and degree) of albuminuria.
Glomerular Filtration and microalbuminuria:
- evidence from a Norwegian cohort study reveals that the combination of a glomerular filtration rate < 45 ml/min/1.73m^2 and microalbuminuria was a strong predictor of cardiovascular death (2)
- reduced kidney function and microalbuminuria were risk factors for cardiovascular death, independent of each other and traditional risk factors
- a US study revealed that moderately decreased estimated GFR and albuminuria independently predict cardiovascular and all-cause mortality in the general population (3)
Reference:
- (1) Gerstein HG et al, for the HOPE study investigators. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and non-diabetic individuals. JAMA 2001;286:421-6.
- (2) Hallan S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. Arch Intern Med. 2007 Dec 10;167(22):2490-6.
- (3) Astor BC et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol. 2008 May 15;167(10):1226-34
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.